The role of the pacemaker current If in cardiovascular pharmacology

Pharmacological Research

Volumn 53, Issue 5, 2006, Pages 397-398

  Mugelli, Alessandro ^a  

^a Department of Preclinical and Clinical Pharmacology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; IVABRADINE;

CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; DRUG INHIBITION; DRUG MECHANISM; DRUG TARGETING; EDITORIAL; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART DISEASE; HEART RATE; HEART VENTRICLE REMODELING; HUMAN; ION CURRENT; PACEMAKER; PACEMAKER NERVE CELL; PRIORITY JOURNAL; SINUS NODE; STABLE ANGINA PECTORIS;

EID: 33646543381     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.03.014     Document Type: Editorial

References (6)

1. DiFrancesco D. Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol Res 2006; this issue.
2. Ferrari R, Cargnoni A, Ceconi C. Anti-ischaemic effect of ivabradine. Pharmacol Res 2006; this issue.
3. f blockade: evidence and perspective. Pharmacol Res 2006; this issue.
4. f current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease. Pharmacol Res 2006; this issue.
5. f in non-pacemaker cells: role and pharmacological implications. Pharmacol Res 2006; this issue.
6. f and the biological pacemaker. Pharmacol Res 2006; this issue.